Hematopoietic Growth Factors: Understanding Functional Diversity in Structural Terms
Overview
Authors
Affiliations
Patel N, Castillo M, Rameshwar P Biol Proced Online. 2008; 9:56-64.
PMID: 18335004 PMC: 2266633. DOI: 10.1251/bpo133.
Hypoxia alters progression of the erythroid program.
Rogers H, Yu X, Wen J, Smith R, Fibach E, Noguchi C Exp Hematol. 2007; 36(1):17-27.
PMID: 17936496 PMC: 2424406. DOI: 10.1016/j.exphem.2007.08.014.
The significance of substance P in physiological and malignant haematopoiesis.
Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B J Clin Pathol. 2006; 60(7):749-55.
PMID: 17172475 PMC: 1995773. DOI: 10.1136/jcp.2006.041475.
Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.
Chatta G, Dale D Drugs Aging. 1996; 9(1):37-47.
PMID: 8818584 DOI: 10.2165/00002512-199609010-00004.
A circularly permuted recombinant interleukin 4 toxin with increased activity.
Kreitman R, Puri R, Pastan I Proc Natl Acad Sci U S A. 1994; 91(15):6889-93.
PMID: 8041715 PMC: 44303. DOI: 10.1073/pnas.91.15.6889.